Q2 Earnings Forecast for Nukkleus Issued By Noble Financial

Nukkleus Inc. (NASDAQ:DFNS) – Noble Financial lifted their Q2 2026 earnings per share estimates for shares of Nukkleus in a report issued on Tuesday, July 21st. Noble Financial analyst J. Gomes now anticipates that the company will post earnings per share of ($3.11) for the quarter, up from their previous forecast of ($8.75). Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($63.98) per share. Noble Financial also issued estimates for Nukkleus’ Q3 2026 earnings at ($2.70) EPS, Q4 2026 earnings at ($2.30) EPS, FY2026 earnings at ($4.21) EPS, FY2027 earnings at ($7.27) EPS and FY2028 earnings at ($2.18) EPS.

Nukkleus (NASDAQ:DFNS) last issued its earnings results on Wednesday, May 20th. The company reported ($142.50) earnings per share for the quarter. The business had revenue of $3.65 million during the quarter.

Several other research analysts have also recently issued reports on DFNS. Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday. Wall Street Zen lowered shares of Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday, April 18th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy”.

Nukkleus Stock Performance

DFNS stock opened at $3.90 on Thursday. Nukkleus has a 1-year low of $3.80 and a 1-year high of $1,948.75. The business has a 50-day moving average price of $28.14 and a 200 day moving average price of $143.15. The company has a market capitalization of $2.96 million, a P/E ratio of -1.33 and a beta of -5.82. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21.

Institutional Investors Weigh In On Nukkleus

A number of hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets purchased a new position in Nukkleus in the second quarter valued at about $56,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Nukkleus during the fourth quarter valued at about $57,000. GM Advisory Group LLC bought a new stake in shares of Nukkleus in the 4th quarter valued at about $56,000. Millennium Management LLC bought a new stake in shares of Nukkleus in the 4th quarter valued at about $60,000. Finally, Ausdal Financial Partners Inc. purchased a new position in shares of Nukkleus in the 3rd quarter worth approximately $105,000. 12.47% of the stock is currently owned by hedge funds and other institutional investors.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.